Given the previous studies for ITGAM/CD11b, LAPTM5 and LILRB4, it is tempting to speculate that they are involved in phagocytic processes involving synapses which are known to be reactivated during Alzheimer’s disease progression. Here, LAPTM5 is linked to early-onset autosomal dominant Alzheimer disease.